Omega Healthcare Investors, Inc. (NYSE:OHI) Shares Sold by Waterfront Capital Partners LLC

Waterfront Capital Partners LLC lowered its stake in Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 35.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 532,722 shares of the real estate investment trust's stock after selling 293,572 shares during the quarter. Omega Healthcare Investors comprises about 3.0% of Waterfront Capital Partners LLC's portfolio, making the stock its 12th biggest holding. Waterfront Capital Partners LLC owned about 0.20% of Omega Healthcare Investors worth $21,682,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently bought and sold shares of the company. Versant Capital Management Inc purchased a new position in shares of Omega Healthcare Investors during the 2nd quarter worth approximately $26,000. UMB Bank n.a. lifted its stake in Omega Healthcare Investors by 353.4% during the third quarter. UMB Bank n.a. now owns 662 shares of the real estate investment trust's stock worth $27,000 after purchasing an additional 516 shares in the last quarter. DiNuzzo Private Wealth Inc. purchased a new position in shares of Omega Healthcare Investors during the third quarter worth $33,000. V Square Quantitative Management LLC grew its stake in shares of Omega Healthcare Investors by 49.5% in the third quarter. V Square Quantitative Management LLC now owns 976 shares of the real estate investment trust's stock valued at $40,000 after buying an additional 323 shares in the last quarter. Finally, Truvestments Capital LLC acquired a new position in Omega Healthcare Investors during the 3rd quarter worth about $43,000. Hedge funds and other institutional investors own 65.25% of the company's stock.

Omega Healthcare Investors Stock Down 0.1 %

NYSE OHI traded down $0.04 during trading on Friday, reaching $40.63. 1,091,023 shares of the company's stock were exchanged, compared to its average volume of 1,686,701. The company has a 50 day moving average price of $40.61 and a two-hundred day moving average price of $37.31. The stock has a market cap of $10.97 billion, a P/E ratio of 29.88, a price-to-earnings-growth ratio of 1.27 and a beta of 0.99. Omega Healthcare Investors, Inc. has a 1 year low of $27.53 and a 1 year high of $44.42. The company has a debt-to-equity ratio of 1.10, a quick ratio of 6.48 and a current ratio of 6.48.

Omega Healthcare Investors Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Monday, November 4th were paid a dividend of $0.67 per share. This represents a $2.68 annualized dividend and a yield of 6.60%. The ex-dividend date was Monday, November 4th. Omega Healthcare Investors's payout ratio is 197.06%.

Insider Activity at Omega Healthcare Investors

In other news, COO Daniel J. Booth sold 56,725 shares of Omega Healthcare Investors stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the sale, the chief operating officer now owns 100,000 shares in the company, valued at approximately $4,025,000. The trade was a 36.19 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Robert O. Stephenson sold 22,542 shares of the business's stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.19, for a total value of $905,962.98. Following the completion of the sale, the chief financial officer now directly owns 183,076 shares of the company's stock, valued at $7,357,824.44. The trade was a 10.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.37% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

OHI has been the subject of several research reports. Truist Financial lifted their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a "hold" rating in a research report on Wednesday, September 4th. Wells Fargo & Company restated an "overweight" rating and issued a $43.00 price objective (up previously from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday, October 1st. Scotiabank upped their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a "sector perform" rating in a research note on Monday, August 26th. BMO Capital Markets raised their price target on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the company a "market perform" rating in a research report on Monday, October 7th. Finally, Royal Bank of Canada upped their price objective on Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a "sector perform" rating in a research report on Monday, November 11th. Seven investment analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $40.00.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.